5-HT_2A Receptor Activation Normalizes Exaggerated Fear Behavior in p-Chlorophenylalanine (PCPA)-Treated Rats.

Area of Science:

• Neuroscience
• Pharmacology
• Behavioral Science

Background:

• Serotonin (5-hydroxytryptamine, 5-HT) neurotransmission is linked to emotional behaviors, but specific receptor roles remain unclear.
• Deficits in 5-HT are associated with abnormal emotionality, including heightened aggression, anxiety, and depression.

Purpose of the Study:

• To investigate the role of serotonin 5-HT2 receptors in regulating learned fear.
• To examine the effects of 5-HT depletion on fear potentiated startle (FPS) and the potential therapeutic effects of 5-HT2 receptor agonists.

Main Methods:

• Rats were chronically treated with p-chlorophenylalanine (PCPA) to deplete brain 5-HT, creating a model of 5-HT deficiency.
• Fear potentiated startle (FPS) was measured in PCPA-treated and control rats.
• The effects of the 5-HT2 receptor agonist DOI and antagonists ketanserin (5-HT2A selective) and SB 206553 (5-HT2B/2C selective) on FPS were assessed.

Main Results:

• PCPA-treated rats exhibited an enhanced magnitude of FPS, indicating exaggerated learned fear.
• Systemic administration of DOI significantly reduced FPS in both PCPA-treated and control rats, normalizing the fear response in PCPA-treated animals.
• The DOI-induced reduction in learned fear was blocked by ketanserin but not by SB 206553, implicating 5-HT2A receptors.

Conclusions:

• Serotonin 5-HT2A receptors play a critical role in regulating learned fear.
• Targeting 5-HT2A receptors may be a viable strategy for normalizing exaggerated learned fear in conditions involving 5-HT disruption.